Display Settings:

Format

Send to:

Choose Destination
Accession: PRJNA175066 ID: 175066

Homo sapiens (human)

Safety and efficacy of CYT387, a JAK1 and JAK2 inhibitor, in myelofibrosis

See Genome Information for Homo sapiens
17 patients with myelofibrosis contributed paired research samples; the time points were pre-study and 12 weeks after commencing study treatment with CYT387. More...
AccessionPRJNA175066; GEO: GSE40841
Data TypeTranscriptome or Gene expression
ScopeMultiisolate
OrganismHomo sapiens[Taxonomy ID: 9606]
Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae; Homo; Homo sapiens
PublicationsPardanani A et al., "Safety and efficacy of CYT387, a JAK1 and JAK2 inhibitor, in myelofibrosis.", Leukemia, 2013 Jun;27(6):1322-7
SubmissionRegistration date: 12-Sep-2012
Dr. Pardanani, Hematology, Mayo Clinic
RelevanceMedical
Project Data:
Resource NameNumber
of Links
Publications
PubMed1
PMC1
Other datasets
GEO DataSets1
GEO Data Details
ParameterValue
Data volume, Spots1605854
Data volume, Processed Mbytes44
Data volume, Supplementary Mbytes10

Supplemental Content

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...
Support Center